[Pneumocystosis during HIV infection]
M El Fane1, M Sodqi1, A Oulad Lahsen1
1Service des maladies infectieuses, CHU Ibn-Rochd, Casablanca, Maroc.
Abstract:
Pneumocystosis is an opportunistic disease caused by invasion of unicellular fungus Pneumocystic jirovecii which is responsible for febrile pneumonia among patients with cellular immunodeficiency especially those HIV infected. Despite the decreasing of its incidence due to the introduction of antiretroviral therapy, as well as anti-Pneumocystis prophylaxis among these patients, Pneumocystis pneumonia remains the first AIDS-defining event and a leading cause of mortality among HIV-infected patients. The usual radiological presentation is that of diffuse interstitial pneumonia. The diagnosis is confirmed by the detection of trophozoides and/or cysts P. jirovecii in bronchoalveolar lavage (BAL) samples using several staining techniques. The use of polymerase chain reaction in the BAL samples in conjunction with standard immunofluorescent or colorimetric tests have allowed for more has allowed for more rapid and accurate diagnosis. The standard regimen of treatment is the association of trimethoprim-sulfamethoxazole which has been utilized as an effective treatment with a favourable recovery. Early HIV diagnosis and antiretroviral therapy should reduce the incidence of this dreaded disease.
Insights
Pneumocystis pneumonia, caused by Pneumocystis jirovecii fungus, is a significant threat in immunocompromised patients, particularly those with HIV/AIDS. Early diagnosis and treatment with trimethoprim-sulfamethoxazole are crucial for recovery.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunology
Background:
- Pneumocystosis is an opportunistic infection caused by Pneumocystis jirovecii.
- It primarily affects individuals with compromised cellular immunity, notably HIV-infected patients.
- Despite advances, Pneumocystis pneumonia (PCP) remains a leading cause of mortality and an AIDS-defining illness.
Purpose of the Study:
- To review the characteristics, diagnosis, and treatment of Pneumocystis pneumonia.
- To highlight the importance of early diagnosis and management in HIV-infected individuals.
Main Methods:
- Review of radiological findings, typically diffuse interstitial pneumonia.
- Diagnostic confirmation through detection of P. jirovecii in bronchoalveolar lavage (BAL) samples.
- Utilizing staining techniques, immunofluorescence, colorimetric tests, and PCR for rapid and accurate diagnosis.
Main Results:
- Pneumocystis pneumonia presents radiologically as diffuse interstitial pneumonia.
- Polymerase chain reaction (PCR) enhances diagnostic speed and accuracy.
- Trimethoprim-sulfamethoxazole is the standard effective treatment, leading to favorable recovery.
Conclusions:
- Pneumocystis pneumonia remains a critical opportunistic infection in HIV-positive individuals.
- Prompt diagnosis and effective treatment with trimethoprim-sulfamethoxazole are vital.
- Early HIV diagnosis and antiretroviral therapy are key to reducing PCP incidence.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:14An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
